Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of turoctocog alfa in male patients (Japan)
jRCT2080222493Phase 3Completed
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3 trial of turoctocog alfa in hemophilia A. Started May 2014; status: completed.
02
Drugs
turoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on jRCT2080222493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222493.